Literature DB >> 8951351

Induction of liver and kidney CYP1A1/1A2 by caffeine in rat.

T Goasduff1, Y Dréano, B Guillois, J F Ménez, F Berthou.   

Abstract

Caffeine metabolism by hepatic microsomal P450 enzymes is well documented in experimental animals and humans. However, its induction effect on P450 enzymes has not been thoroughly studied. In a preliminary experiment, the time-dependent incubation of 1 mM caffeine with rat hepatocyte culture resulted in an increase of its own metabolic rate. The dose-dependent expression of rat hepatic and renal cytochromes (CYP) 1A1/1A2 was then investigated after per os administration of caffeine. P450 expression was monitored by using specific enzymatic activities and Northern blot analysis. Caffeine caused a dose-dependent elevation of hepatic CYP1A1/1A2 activities in microsomal preparations, which ranged from 1.7- to 6-fold for ethoxyresorufin O-deethylase and 3- to 8.9-fold for methoxy-resorufin O-demethylase according to the dose regimen of 50 and 150 mg caffeine/kg/day for 3 days, respectively. Northern blot analysis demonstrated that caffeine treatment increased liver CYP1A1 and CYP1A2 mRNA levels over the dose regimen of 50-150 mg caffeine/kg/day for 3 days, respectively. The result of this study demonstrates that caffeine increases its own metabolism in a dose-dependent manner and induces CYP1A1/1A2 expression through either transcriptional activation or mRNA stabilization.

Entities:  

Mesh:

Substances:

Year:  1996        PMID: 8951351     DOI: 10.1016/s0006-2952(96)00522-9

Source DB:  PubMed          Journal:  Biochem Pharmacol        ISSN: 0006-2952            Impact factor:   5.858


  10 in total

Review 1.  Dietary effects on drug metabolism and transport.

Authors:  Robert Z Harris; Graham R Jang; Shirley Tsunoda
Journal:  Clin Pharmacokinet       Date:  2003       Impact factor: 6.447

2.  Drug-phytochemical interactions.

Authors:  Costas Ioannides
Journal:  Inflammopharmacology       Date:  2003       Impact factor: 4.473

3.  Caffeine, selected metabolic gene variants, and risk for neural tube defects.

Authors:  Rebecca J Schmidt; Paul A Romitti; Trudy L Burns; Jeffrey C Murray; Marilyn L Browne; Charlotte M Druschel; Richard S Olney
Journal:  Birth Defects Res A Clin Mol Teratol       Date:  2010-07

4.  Caffeine induction of sulfotransferases in rat liver and intestine.

Authors:  Tianyan Zhou; Yue Chen; Chaoqun Huang; Guangping Chen
Journal:  J Appl Toxicol       Date:  2011-07-01       Impact factor: 3.446

5.  Dietary caffeine as a probe agent for assessment of cytochrome P4501A2 activity in random urine samples.

Authors:  A Nordmark; S Lundgren; S Cnattingius; A Rane
Journal:  Br J Clin Pharmacol       Date:  1999-04       Impact factor: 4.335

6.  Fourteen-week toxicity study of green tea extract in rats and mice.

Authors:  Po C Chan; Yuval Ramot; David E Malarkey; Pamela Blackshear; Grace E Kissling; Greg Travlos; Abraham Nyska
Journal:  Toxicol Pathol       Date:  2010-09-30       Impact factor: 1.902

7.  Acute and subacute oral toxicity assessment of dry encapsulated and non-encapsulated green coffee fruit extracts.

Authors:  Wanessa Costa Silva Faria; Alessandra Almeida da Silva; Natalie Veggi; Nair Honda Kawashita; Suelem A de França Lemes; Wander Miguel de Barros; Edemilson da Conceição Cardoso; Attilio Converti; Waldênia de Melo Moura; Neura Bragagnolo
Journal:  J Food Drug Anal       Date:  2020-06-15       Impact factor: 6.157

8.  Modulation of CYP1A1 and CYP1A2 hepatic enzymes after oral administration of Chios mastic gum to male Wistar rats.

Authors:  Efrosini S Katsanou; Katerina Kyriakopoulou; Christina Emmanouil; Nikolas Fokialakis; Alexios-Leandros Skaltsounis; Kyriaki Machera
Journal:  PLoS One       Date:  2014-06-20       Impact factor: 3.240

9.  Response differences of HepG2 and Primary Mouse Hepatocytes to morphological changes in electrospun PCL scaffolds.

Authors:  Thomas S R Bate; Victoria L Gadd; Stuart J Forbes; Anthony Callanan
Journal:  Sci Rep       Date:  2021-02-04       Impact factor: 4.379

10.  Assessment of CYP1A2 enzyme activity in relation to type-2 diabetes and habitual caffeine intake.

Authors:  Emily Urry; Alexander Jetter; Hans-Peter Landolt
Journal:  Nutr Metab (Lond)       Date:  2016-10-06       Impact factor: 4.169

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.